MedPath

Non-bridging Fixator Versus Percutaneous Pinning for Distal Radius Fractures

Phase 3
Completed
Conditions
Radius Fractures
Registration Number
NCT00908895
Lead Sponsor
Hopital de l'Enfant-Jesus
Brief Summary

The treatment of extra-articular distal radius fractures is still controversial. In Canada, most patients with unstable fractures are treated with pinning and cast. Results are often associated with shortening and lack of function.

The purpose of the study is to compare stabilization with a radio-radial fixator to the usual method, suggesting that the radio-radial fixator will provide more strength at 6 months follow-up.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Distal radius fracture Frykman I or II
  • Unstable fracture according to Lafontaine's criteria
  • Fracture line more than 1cm form the joint line
  • Closed fracture
  • Age > 18 years
  • Surgery performed between 72 hours from the trauma
  • Monotrauma
  • Patient signed the informed consent
Exclusion Criteria
  • Distal radius fracture Frykman III-VI (intra-articular fracture)
  • Open fracture
  • Polytraumatism
  • Stable or non-displaced fracture

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The Grip Strength6 months

Grip strength measured with Jamar dynamometer in kilograms and adjusted to the opposite side in percentage. Correction made according to dominance.

Secondary Outcome Measures
NameTimeMethod
Range of Movement of Wrist6 months

Range of motion were divided in subgroups: dorsal flexion, volar flexion, pronation, supination, radial inclination, cubital inclination.

Motion is described as a percentage of the opposite side.

Trial Locations

Locations (1)

Département d'orthopédie, CHA-Pavillon Enfant-Jésus

🇨🇦

Québec, Quebec, Canada

Département d'orthopédie, CHA-Pavillon Enfant-Jésus
🇨🇦Québec, Quebec, Canada

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.